SiteOne Therapeutics logo

SiteOne Therapeutics

Bozeman, MT

SiteOne Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of hypersensitivity disorders such as chronic cough, itch, and pain.

siteonetherapeutics.com

Company Details

Founded

2014

Employees

Between 10 - 50 employees

Raised

$134,178,360

Headquarters Location

Bozeman, MT

Public

No

Acquired

Yes

CEO

John MulcahyJohn Mulcahy

Founders

George Miljanich
George Miljanich
David Yeomans
David Yeomans

Company Collections

These are collections SiteOne Therapeutics is a part of. Click on the collection name to view similar companies.

SiteOne Therapeutics' Industries

SiteOne Therapeutics Headquarters Location

960 Technology Boulevard, Bozeman, MT 59718

Total Amount Raised: $134,178,360

SiteOne Therapeutics Funding Rounds

  • Series C

    $100,000,000

    Series C Investors

    Novo Holdings
    BSQUARED Capital
    OrbiMed Advisors
    Mission BioCapital
    Wellington Management

  • Grant

    $15,000,000

    Grant Investors

    National Institute on Drug Abuse (NIDA)

  • Series B

    $15,000,000

    Series B Investors

    Amgen
    Next Frontier Capital
    2M
    Mission Bay Capital
    Sears Capital Management
    Z Investments
    BioBrit
    Mission BioCapital

  • Series Unknown

    $1,278,358

    Series Unknown Investors

    Next Frontier Capital
    Sears Capital Management
    Mission Bay Capital
    BioBrit

  • Series A

    $1,500,000

    Series A Investors

    Sears Capital Management
    Bay Capital
    BioBrit
    Joe Zakrzewski

  • Grant

    $1,400,000

Funding info provided by Diffbot.

SiteOne Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on SiteOne Therapeutics.

Recent reviews